Page last updated: 2024-08-24

safranal and Granulocytic Leukemia, Chronic

safranal has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Geromichalos, GD; Papadopoulos, T; Sahpazidou, D; Sinakos, Z	1

Other Studies

1 other study(ies) available for safranal and Granulocytic Leukemia, Chronic

Article	Year
Safranal, a Crocus sativus L constituent suppresses the growth of K-562 cells of chronic myelogenous leukemia. In silico and in vitro study. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 74 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Carotenoids; Cell Line, Tumor; Computer Simulation; Crocus; Cyclohexenes; Fusion Proteins, bcr-abl; Gene Expression; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Piperazines; Pyrimidines; Terpenes	2014

Article

Year

Safranal, a Crocus sativus L constituent suppresses the growth of K-562 cells of chronic myelogenous leukemia. In silico and in vitro study.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 74

Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Carotenoids; Cell Line, Tumor; Computer Simulation; Crocus; Cyclohexenes; Fusion Proteins, bcr-abl; Gene Expression; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Piperazines; Pyrimidines; Terpenes

2014